[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_5006 

# __Cytotoxicity of graphene derivatives due to negatively charged groups__

## Articles mentionning the risk

* [Ayub_graphene-based_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_404.md)

## Mitigations of this risk

* [Testing and regulation of graphene derivatives, development of safer alternatives](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_6879.md)

## Name of the risk

Potential harm to human and animal cells

## People affected by this risk

* [Manufacturers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Regulatory bodies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_706.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_34.md)

## Stakeholders who can mitigate this risk

* [Regulatory bodies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_706.md)

## Technologies linked to the risk

* [Biocompatibility testing](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_267.md)
* [Regulatory oversight](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6073.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

